Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/06/2821 : 32PR Newswire (US)Splash Box Marketing LLC Earns 2024 Great Place To Work Certification™
2024/06/2821 : 32PR Newswire (US)O'Shaughnessy Ventures Awards $100,000 Fellowship Grant to Biotech Entrepreneur Aiming to Revolutionize Microbiome Health Monitoring
2024/06/2821 : 32PR Newswire (US)Easy Street Offers Expands into Nine New States on June, 30th, 2024
2024/06/2821 : 31GlobeNewswire Inc.Reborn Coffee Collaborates with Hagerty Garage + Social to Celebrate Hagerty's 40th Anniversary in South FloridaNASDAQ:REBNReborn Coffee Inc
2024/06/2821 : 31PR Newswire (US)Massimo Group to Ring the Nasdaq Closing Bell on Monday, July 15, 2024NASDAQ:MAMOMassimo Group
2024/06/2821 : 31PR Newswire (US)AIAA to Present Aerospace Excellence Awards During 2024 ASCEND
2024/06/2821 : 31Business WireProcaps Group Announces New ChairmanNASDAQ:PROCProcaps Group SA
2024/06/2821 : 31GlobeNewswire Inc.Global Water Resources Declares Monthly DividendTSX:GWRGWR Global Water Resources Inc
2024/06/2821 : 31GlobeNewswire Inc.Global Water Resources Declares Monthly DividendNASDAQ:GWRSGlobal Water Resources Inc
2024/06/2821 : 30Business WireAlmirall’s Ilumetri® (tildrakizumab) Restores and Maintains Wellbeing of Patients With Moderate-to-severe Plaque Psoriasis to the Levels of the General Population for up to 1 Year1
2024/06/2821 : 30Business WireGraham Corporation Set To Join Russell 2000® and 3000® IndexesNYSE:GHMGraham Corp
2024/06/2821 : 30GlobeNewswire Inc.Safety Shot President Jordan Schur Invests $1 Million in the Company Through his Family Fund, Core 4 Capital Corp.NASDAQ:SHOTWSafety Shot Inc
2024/06/2821 : 30GlobeNewswire Inc.Safety Shot President Jordan Schur Invests $1 Million in the Company Through his Family Fund, Core 4 Capital Corp.NASDAQ:SHOTSafety Shot Inc
2024/06/2821 : 30GlobeNewswire Inc.Falco Announces Resignation of Board MemberTSXV:FPCFalco Resources Ltd
2024/06/2821 : 30GlobeNewswire Inc.Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast CancerNASDAQ:ATOSAtossa Therapeutics Inc
2024/06/2821 : 30GlobeNewswire Inc.Actelis Receives Order from Major German Municipal Utilities CompanyNASDAQ:ASNSActelis Networks Inc
2024/06/2821 : 30GlobeNewswire Inc.Fluent, Inc. Announces Inclusion in Russell Microcap® IndexNASDAQ:FLNTFluent Inc
2024/06/2821 : 30GlobeNewswire Inc.Callan JMB Inc. Supports Chicago Department of Public Health in Containing Measles Outbreak through Comprehensive Vaccine Management Plan
2024/06/2821 : 30Business WireMirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTXNASDAQ:MIRMMirum Pharmaceuticals Inc
2024/06/2821 : 30GlobeNewswire Inc.Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization PartnershipNASDAQ:DYAIDyadic International Inc
2024/06/2821 : 30GlobeNewswire Inc.Stran & Company Reports Preliminary Selected Unaudited Results for the First Quarter of 2024NASDAQ:SWAGWStran and Company Inc
2024/06/2821 : 30GlobeNewswire Inc.Stran & Company Reports Preliminary Selected Unaudited Results for the First Quarter of 2024NASDAQ:SWAGStran and Company Inc
2024/06/2821 : 30GlobeNewswire Inc.Cheetah Net Moves Its Headquarters to Los AngelesNASDAQ:CTNTCheetah Net Supply Chain Service Inc
2024/06/2821 : 30Business WireBlackstone Mortgage Trust Announces Second Quarter 2024 Earnings Release and Conference CallNYSE:BXMTBlackstone Mortgage Trust Inc
2024/06/2821 : 30GlobeNewswire Inc.Stran & Company Reports Preliminary Selected Unaudited Results for the First Quarter of 2024TG:S9HStran & Company Inc
2024/06/2821 : 30GlobeNewswire Inc.NANO Nuclear Energy Praises Congress for its Bipartisan Passage of the ‘ADVANCE’ Act to Boost Advanced Nuclear Technology Deployment and Strengthen U.S. Energy IndependenceNASDAQ:NNENano Nuclear Energy Inc
2024/06/2821 : 30GlobeNewswire Inc.Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of ResultsNASDAQ:INBSIntelligent Bio Solutions Inc
2024/06/2821 : 30PR Newswire (US)B612 Foundation Announces Inaugural Schweickart Prize Winner
2024/06/2821 : 30PR Newswire (US)Gallup recognizes Travelex Insurance Services for strengths-based culture
2024/06/2821 : 30PR Newswire (US)Incorporating Regulatory Affairs Into Your Quality Management System, Upcoming Webinar Hosted by Xtalks

最近閲覧した銘柄